Wynne-Jones IP Ready for the EU Referendum Outcome

Wynne-Jones IP Ready for the EU Referendum Outcome

Possible Outcomes

A “Bremain” outcome will simply mean business as usual across the UK and Europe.

A “Brexit” vote for the UK to withdraw from the EU will inevitably result in a degree of uncertainty for all businesses.  No one can predict what exactly will happen as the British Government and the EU would need to hold negotiations to agree the terms of Britain’s withdrawal (no country has previously withdrawn from the EU).  The negotiations would be expected to take at least two years.  During the negotiations EU law will continue to be in force in the UK.

We would like to reassure all of our clients that we do not believe they have any reason to be concerned about the immediate impact of a “Brexit” on their Intellectual Property rights.

All IP Rights will remain in force in the immediate future and provisions for any transition of IP rights will of course be part of the government negotiations.  It is also important to note that the European Patent Convention will be unaffected by the Referendum result as it is independent of the European Union (and already includes several non-EU member states).

 

 

 

 

Our AIPEX Alliance
AIPEX logo_new

Wynne-Jones IP is committed to supporting our clients through any changes in the European IP landscape.  Our clients are able to benefit from our position as a founding member of the unique European alliance of independent IP law firms – AIPEX.

AIPEX, was founded in 2010, and is registered in Munich, Germany.  AIPEX has partner members in key industrial territories of Europe: Wynne-Jones in the UK,  AOMB in The Netherlands, Germain & Maureau  in France and  Prinz & Partner  in Germany.  AIPEX also has Associate partners in Spain (Herrero & Asociados), Hungary (SBGK) and Poland (AOMB Polska).

AIPEX allows us to work together as a team of over 200 professionals to combine national and local knowledge as well as professional capacity and experience in all the necessary technical and legal specialties.

As such, in the event of a “Brexit” Wynne-Jones will be able to provide an agile and adaptable response to any resulting changes related to IP in Europe.  We will be able to provide our clients with tailored and flexible services across Europe to meet whatever needs may arise.

 

Related News

news

Coronavirus - UK IPO, EPO and EU IPO extensions and support

A simple overview of the current status from IPOs. Last updated 31st March 2020. 

UPDATE - UK IPO support for those affected by Coronavirus
news

UPDATE - UK IPO support for those affected by Coronavirus

The UKIPO has now certified that a ‘period of interruption’ began on Tuesday 24 March 2020.

BREAKING NEWS - German Federal Constitutional Court decides on UPC complaint
news

BREAKING NEWS - German Federal Constitutional Court decides on UPC complaint

The German Federal Constitutional Court has now issued its long-awaited decision (source) in case  2 BvR 739/17 which was a complaint against the German Ratification Law under which Germany was to ratify the UPC.

EPO announces extensions to deadlines due to COVID-19
news

EPO announces extensions to deadlines due to COVID-19

On Sunday 15 March 2020 the EPO published a notice advising it is invoking the provisions of Rule 134(2) EPC, and has extended all periods expiring on or after publication of the notice to 17 April 2020. This may be extended by the EPO upon publication of a further notice.

EUIPO extends all deadlines for Community Design and European Union Trade Marks
news

EUIPO extends all deadlines for Community Design and European Union Trade Marks

The Executive Director of the EUIPO has today (16 March 2020) issued a decision regarding extensions for all time limits on trade mark and design matters at the EUIPO. In accordance with the decision, all time limits expiring between 9 March 2020 and 30 April 2020 inclusive are extended until 1 May 2020.

news

UK IPO announces support for those affected by coronavirus

In brief, the UK IPO has indicated that it will use its discretionary powers (on a case-by-case basis) to extend time limits where possible under national and international law.

*Update* “EPO Board of Appeal finds Broad Institute’s CRISPR patent to lack valid priority claim and upholds revocation of patent (T 0844/18)”
news

*Update* “EPO Board of Appeal finds Broad Institute’s CRISPR patent to lack valid priority claim and upholds revocation of patent (T 0844/18)”

Earlier this year, we reported on the EPO Board of Appeal’s decision to uphold the revocation of the Broad Institute’s CRISPR patent (here). Now it appears that the Broad Institute is gearing up to put forward a petition for review by the Enlarged Board of Appeal as a last resort to save their patent.

news

The UPC is dead, long live the UPC!

European patent attorneys have been getting excited about the Unitary Patent (UP) and Unified Patent Court (UPC) for years, writing articles, and giving talks and presentations about the ins-and-outs and twists-and-turns of the whole thing. So what is the current situation? What has happened now?

aipex logo aipex logo aipex logo